N/A
N=16
Reducing Loneliness of Older Adults in Long Term Care Facilities Through Collaborative Augmented Realities
Loneliness
Bottom Line
View on ClinicalTrials.gov: NCT06179225 ↗Enrolled (actual)
16
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: Feasibility of Intervention — 18.0; 19.7; 16.2; 16.7 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- HMD AR (Behavioral); 2-D AV (Behavioral)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Vanderbilt University
- Primary completion
- Apr 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Intervention |
18.0; 19.7; 16.2; 16.7 | — |
| PRIMARY Acceptability of Intervention Questionnaire |
17.0; 17.3; 16.2; 18.3 | — |
| PRIMARY UCLA Loneliness Scale |
9.6; 12.7; 8.0; 15.3; 9.6; 11.7 | — |
| PRIMARY Networked Minds Measure (NMM) of Social Presence |
3.2; 2.3; 2.7; 2.2 | — |
Summary
The goal of this clinical trial is to test the use of head-mounted display (HMD) augmented reality (AR) in older adults residing in communities or assisted care facilities. The main questions it aims to answer are: what is the feasibility, acceptability, and satisfaction of HMD AR vs two-dimensional audio-video communication? Older adults and their designated family member will complete HMD AR activities in 8 session visits over 4 weeks. Researchers will compare HMD AR to 2-D audio-visual (AV) comparison group on feasibility, acceptability, and satisfaction with the interactive communication technology.
Eligibility Criteria
Inclusion Criteria
- age 60 and older
- residing at home in community
- if residing in assisted living facility, more than 3 months
Exclusion Criteria
- unable to provide assent or consent
- unable to understand or speak English
- physical impairment that impedes participation
- terminally ill
Data sourced from ClinicalTrials.gov (NCT06179225). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.